<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36879337</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3106</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Advances in rheumatology (London, England)</Title><ISOAbbreviation>Adv Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Blood levels of brain-derived neurotrophic factor (BDNF) in systemic lupus erythematous (SLE): a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42358-023-00291-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES">BDNF has been implicated in the pathophysiology of systemic lupus erythematosus (SLE), especially its neuropsychiatric symptoms. The purpose of this study was to investigate the profile of blood BDNF levels in patients with SLE.</AbstractText><AbstractText Label="METHODS">We searched PubMed, EMBASE, and the Cochrane Library for papers that compared BDNF levels in SLE patients and healthy controls (HCs). The Newcastle-Ottawa scale was used to assess the quality of the included publications, and statistical analyses were carried out using R 4.0.4.</AbstractText><AbstractText Label="RESULTS">The final analysis included eight studies totaling 323 healthy controls and 658 SLE patients. Meta-analysis did not show statistically significant differences in blood BDNF concentrations in SLE patients compared to HCs (SMD 0.08, 95% CI [&#x2009;-&#x2009;1.15; 1.32], P&#x2009;value =&#x2009;0.89). After removing outliers, there was no significant change in the results: SMD -0.3868 (95% CI [&#x2009;-&#x2009;1.17; 0.39], P&#x2009;value&#x2009;=&#x2009;0.33. Univariate meta-regression analysis revealed that sample size, number of males, NOS score, and mean age of the SLE participants accounted for the heterogeneity of the studies (R<sup>2</sup> were 26.89%, 16.53%, 18.8%, and 49.96%, respectively).</AbstractText><AbstractText Label="CONCLUSION">In conclusion, our meta-analysis found no significant association between blood BDNF levels and SLE. The potential role and relevance of BDNF in SLE need to be further examined in higher quality studies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shobeiri</LastName><ForeName>Parnian</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, Children's Medical Center Hospital, Tehran University of Medical Sciences (TUMS), Dr. Qarib St., Keshavarz Blvd, Tehran, 14194, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Dr. Gharib St, Keshavarz Blvd, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maleki</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amanollahi</LastName><ForeName>Mobina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Children's Medical Center Hospital, Tehran University of Medical Sciences (TUMS), Dr. Qarib St., Keshavarz Blvd, Tehran, 14194, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habibzadeh</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Children's Medical Center Hospital, Tehran University of Medical Sciences (TUMS), Dr. Qarib St., Keshavarz Blvd, Tehran, 14194, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Antonio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaei</LastName><ForeName>Nima</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3836-1827</Identifier><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Dr. Gharib St, Keshavarz Blvd, Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Rheumatol</MedlineTA><NlmUniqueID>101734172</NlmUniqueID><ISSNLinking>2523-3106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="Y">Brain-Derived Neurotrophic Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Brain-derived neurotrophic factor</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Neuropsychiatry lupus</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematous</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>6</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36879337</ArticleId><ArticleId IdType="doi">10.1186/s42358-023-00291-6</ArticleId><ArticleId IdType="pii">10.1186/s42358-023-00291-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Assun&#xe7;&#xe3;o H, Rodrigues M, Prata AR, Lu&#xed;s M, da Silva JA, In&#xea;s L. Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study. Clin Rheumatol. 2022;41:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06251-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Tsokos GC. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res. 2011;13(2):1&#x2013;10.</Citation></Reference><Reference><Citation>Rekvig OP, Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol. 2014;36(3):301&#x2013;11. https://doi.org/10.1007/s00281-014-0428-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-014-0428-6</ArticleId><ArticleId IdType="pubmed">24763531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleczynska W, Jakiela B, Plutecka H, Milewski M, Sanak M, Musial J. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus. Folia Histochem Cytobiol. 2011;49(4):646&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">22252759</ArticleId><ArticleId IdType="doi">10.5603/FHC.2011.0088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82(5):299&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">14530779</ArticleId><ArticleId IdType="doi">10.1097/01.md.0000091181.93122.55</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol. 2014;261(9):1706&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24952022</ArticleId><ArticleId IdType="doi">10.1007/s00415-014-7406-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Johnson SR. Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus. Expert Rev Clin Immunol. 2022;18(2):135&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">35076341</ArticleId><ArticleId IdType="doi">10.1080/1744666X.2022.2033617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternhagen E, Bettendorf B, Lenert A, Lenert PS. The role of clinical features and serum biomarkers in identifying patients with incomplete lupus erythematosus at higher risk of transitioning to systemic lupus erythematosus: current perspectives. J Inflamm Res. 2022;15:1133&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">35210816</ArticleId><ArticleId IdType="pmc">8863324</ArticleId><ArticleId IdType="doi">10.2147/JIR.S275043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015;13(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0269-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragoso-Loyo H, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS ONE. 2008;3(10):3347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003347</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond B, Volpe BT. A model for lupus brain disease. Immunol Rev. 2012;248(1):56&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">22725954</ArticleId><ArticleId IdType="pmc">4398143</ArticleId><ArticleId IdType="doi">10.1111/j.1600-065X.2012.01137.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Tian B. Brain-derived neurotrophic factor in autoimmune inflammatory diseases (Review). Exp Ther Med. 2021;22(5):1292.</Citation><ArticleIdList><ArticleId IdType="pubmed">34630647</ArticleId><ArticleId IdType="pmc">8461510</ArticleId><ArticleId IdType="doi">10.3892/etm.2021.10727</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J-i, Tandon NN, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 2000;470(2):113&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10734218</ArticleId><ArticleId IdType="doi">10.1016/S0014-5793(00)01302-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemssen T, K&#xfc;mpfel T, Schneider H, Klinkert WE, Neuhaus O, Hohlfeld R. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy. J Neurol Sci. 2005;233(1&#x2013;2):109&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">15869765</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2005.03.010</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio M, De Grazia U, Morrone S, Cuomo L, Spinsanti P, Frati L, et al. Expression of neurotrophin receptors in normal and malignant B lymphocytes. Eur Cytokine Netw. 2000;11(2):283&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">10903808</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets. 2008;7(1):46&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">18289031</ArticleId><ArticleId IdType="doi">10.2174/187152708783885174</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi N, Ashourizadeh H, Pasha BA, Haghshomar M, Jouzdani T, Shobeiri P, Teixeira AL, Rezaei N. Blood levels of brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis (MS): a systematic review and meta-analysis. Mult Scler Relat Disord. 2022;65:103984.</Citation><ArticleIdList><ArticleId IdType="pubmed">35749959</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2022.103984</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobeiri P, Bagherieh S, Mirzayi P, Kalantari A, Mirmosayyeb O, Teixeira AL, Rezaei N. Serum and plasma levels of brain-derived neurotrophic factor in individuals with eating disorders (EDs): a systematic review and meta-analysis. J Eat Disord. 2022;10(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40337-022-00630-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobeiri P, Karimi A, Momtazmanesh S, Teixeira AL, Teunissen CE, van Wegen EE, Hirsch MA, Yekaninejad MS, Rezaei N. Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: a systematic review and meta-analysis of exercise intervention trials. PloS one. 2022;17(3):e0264557.</Citation><ArticleIdList><ArticleId IdType="pubmed">35239684</ArticleId><ArticleId IdType="pmc">8893651</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0264557</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalaji A, Behnoush AH, Shobeiri P, Saeedian B, Teixeira AL, Rezaei N. Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2022;17:1&#x2013;3.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId><ArticleId IdType="pmc">2127453</ArticleId><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, et al. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus. World J Biol Psychiatry. 2010;11(2):121&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109107</ArticleId><ArticleId IdType="doi">10.3109/15622970903521131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauchais A-L, Lise M-C, Marget P, Lapeybie F-X, Bezanahary H, Martel C, et al. Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. PLoS ONE. 2013;8(11): e79414.</Citation><ArticleIdList><ArticleId IdType="pubmed">24223945</ArticleId><ArticleId IdType="pmc">3815153</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0079414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamashiro LF, Oliveira RD, Oliveira R, Frota ERC, Donadi EA, Del-Ben CM, et al. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus. Rheumatology. 2014;53(12):2182&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">24942492</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keu251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinowska-&#x141;yszczarz A, Pawlak MA, Wyciszkiewicz A, Pawlak-Bu&#x15b; K, Leszczy&#x144;ski P, Puszczewicz M, et al. Immune cell neurotrophin production is associated with subcortical brain atrophy in neuropsychiatric systemic lupus erythematosus patients. NeuroImmunoModulation. 2017;24(6):320&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29539621</ArticleId><ArticleId IdType="doi">10.1159/000487139</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, Xu M-J, Cheng J, Chen J-M, Zheng L, Li Z-G. Serum levels of brain-derived neurotrophic factor are associated with depressive symptoms in patients with systemic lupus erythematosus. Psychoneuroendocrinology. 2017;78:246&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237708</ArticleId><ArticleId IdType="doi">10.1016/j.psyneuen.2016.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessi H, Dutra LA, Maria LA, Coube PC, Hoshino K, de Abrantes FF, et al. Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients. Clin Rheumatol. 2022;41(2):421&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34537904</ArticleId><ArticleId IdType="doi">10.1007/s10067-021-05915-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris-Garc&#xed;a E, Arce S, Nardin P, Lanigan M, Acu&#xf1;a V, Gutierrez F, et al. Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous. Lupus. 2018;27(13):2041&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30376438</ArticleId><ArticleId IdType="doi">10.1177/0961203318804899</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian B, Yang C, Wang J, Hou X, Zhao S, Li Y, et al. Peripheral blood brain-derived neurotrophic factor level and tyrosine kinase B expression on T lymphocytes in systemic lupus erythematosus: Implications for systemic involvement. Cytokine. 2019;123: 154764.</Citation><ArticleIdList><ArticleId IdType="pubmed">31255912</ArticleId><ArticleId IdType="doi">10.1016/j.cyto.2019.154764</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Varacallo M. Systemic lupus erythematosus. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright &#xa9; 2022, StatPearls Publishing LLC.; 2022.</Citation></Reference><Reference><Citation>Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">19932376</ArticleId><ArticleId IdType="pmc">2981505</ArticleId><ArticleId IdType="doi">10.1016/j.ncl.2009.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenouchi-Sugita A, Yoshimura R, Ueda N, Kodama Y, Umene-Nakano W, Nakamura J. Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes. Neuropsychiatr Dis Treat. 2008;4(6):1277&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19337469</ArticleId><ArticleId IdType="pmc">2646658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenouchi A, Yoshimura R, Ikemura N, Utsunomiya K, Mitoma M, Nakamura J. Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(7):1359&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16626841</ArticleId><ArticleId IdType="doi">10.1016/j.pnpbp.2006.03.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Colucci-D&#x2019;Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci. 2020;21(20):7777.</Citation><ArticleIdList><ArticleId IdType="pubmed">33096634</ArticleId><ArticleId IdType="pmc">7589016</ArticleId><ArticleId IdType="doi">10.3390/ijms21207777</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.</Citation><ArticleIdList><ArticleId IdType="pubmed">31440144</ArticleId><ArticleId IdType="pmc">6692714</ArticleId><ArticleId IdType="doi">10.3389/fncel.2019.00363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani A, Shenavandeh S, Sepehrtaj SS, Javadpour A. Memory and learning functions in patients with systemic lupus erythematosus: a neuropsychological case-control study. Egypt Rheumatol. 2015;37(4):S13&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2015.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(5):1034&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17459550</ArticleId><ArticleId IdType="doi">10.1016/j.pnpbp.2007.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Umene-Nakano W, Yoshimura R, Ikenouchi-Sugita A, Hori H, Hayashi K, Ueda N, et al. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence. Hum Psychopharmacol. 2009;24(5):409&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19548207</ArticleId><ArticleId IdType="doi">10.1002/hup.1035</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen JP, M&#xf8;rk A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 2006;1110(1):221&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16876769</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2006.06.077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189(5):865&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10049950</ArticleId><ArticleId IdType="pmc">2192942</ArticleId><ArticleId IdType="doi">10.1084/jem.189.5.865</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy. 1997;52(9):883&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">9298172</ArticleId><ArticleId IdType="doi">10.1111/j.1398-9995.1997.tb01247.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50(4):260&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11522260</ArticleId><ArticleId IdType="doi">10.1016/S0006-3223(01)01083-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med. 2010;4(6):871&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">21133708</ArticleId><ArticleId IdType="doi">10.2217/bmm.10.111</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>